Related Experiment Video

Updated: Jun 7, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Drink more, and eat less: advice in obstructive hypertrophic cardiomyopathy

Mayank M Kansal1, Farouk Mookadam, A Jamil Tajik

  • 1Mayo Clinic Arizona, Scottsdale, Arizona, USA. mmkansal@gmail.com

The American Journal of Cardiology
|October 30, 2010
PubMed

Insights

Dietary changes can significantly improve symptoms in obstructive hypertrophic cardiomyopathy patients experiencing postprandial hemodynamic changes. Small, frequent meals and increased noncaffeinated fluids may help avoid invasive treatments.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Nutrition

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) presents with severe symptoms.
  • Patients often undergo evaluation for septal reduction therapy when pharmacologic treatments fail.

Purpose of the Study:

  • To identify and address significant postprandial hemodynamic changes in symptomatic oHCM patients.
  • To explore nonpharmacologic dietary interventions as an alternative to invasive therapies.

Main Methods:

  • Case series of 6 symptomatic oHCM patients.
  • Evaluation through clinical history, physical examination, and echocardiography.
  • Intervention involved dietary counseling: small frequent meals and increased noncaffeinated fluid intake.

Main Results:

  • Identified significant postprandial hemodynamic changes in symptomatic oHCM patients.
  • Dietary modifications led to a reduction in patient symptoms.
  • Nonpharmacologic interventions showed potential to manage symptoms effectively.

Conclusions:

  • Postprandial exacerbation is a key factor in symptomatic oHCM.
  • Dietary interventions may successfully manage oHCM symptoms, potentially obviating the need for septal reduction therapy.
  • Recognizing and managing postprandial changes offers a less invasive treatment avenue.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...